Patient Assistance Agent
Patient Assistance Agent
This AI agent automates the patient assistance workflow for pharmaceutical companies, health systems, and specialty pharmacies. It guides patients through program eligibility, helps them understand copay assistance options, collects required documentation details, and connects them to the right support resources without waiting on hold. With over 33% of American adults reporting difficulty affording their prescription medications and patient assistance programs receiving millions of inquiries annually, organizations need a scalable way to triage requests, answer common questions, and move eligible patients through enrollment faster than phone-based support teams can manage alone.
Patient Assistance Agent
Deploying an AI agent for patient assistance delivers quantifiable improvements in program enrollment, operational efficiency, and patient satisfaction.
The biggest challenge for patient assistance programs is not funding availability but enrollment friction. Industry data shows that fewer than half of eligible patients successfully complete the application process, with abandonment driven by confusing forms, long wait times, and lack of awareness about available programs. AI agents that guide patients conversationally through eligibility and enrollment see completion rates 2-3x higher than static web forms or phone-only intake. For a manufacturer whose patient assistance program receives 50,000 annual inquiries, improving completion from 30% to 60% means 15,000 additional patients receiving the medications they need, with corresponding adherence and outcomes improvements.
Patient assistance call centers are expensive to operate. The average cost per inbound call in healthcare customer service ranges from $8 to $15, and eligibility determination calls average 15-20 minutes each. By automating the initial triage, eligibility screening, and FAQ handling, the AI agent deflects 30-40% of inbound call volume. For a program handling 10,000 calls per month at $12 average cost, that deflection saves $36,000-$48,000 monthly in direct support costs. The savings compound further because agents who do take calls spend less time on routine questions and more time on complex cases that genuinely require human expertise.
Every day a patient waits for assistance program approval is a day without medication. Delays in the enrollment process directly correlate with therapy abandonment: studies show that patients who wait more than 7 days between prescription and first fill are significantly less likely to remain adherent. The AI agent compresses the front end of this timeline by collecting complete case information in a single session rather than across multiple phone calls and fax exchanges. Organizations using conversational AI for patient intake report reducing average time-to-enrollment by 40-60%, which translates directly into faster therapy starts and better clinical outcomes.
Patient Assistance Agent
features
Designed for the complexity of pharmaceutical patient assistance programs where eligibility rules, compliance requirements, and patient anxiety intersect.
Patient assistance programs have complex qualification criteria that vary by manufacturer, insurance status, and income level. The AI agent walks patients through a structured eligibility assessment, asking about their insurance coverage, household income range, prescribed medication, and diagnosis. Patients who clearly qualify are fast-tracked to enrollment. Those who do not are directed to alternative resources such as state pharmaceutical assistance programs or nonprofit foundations. This pre-screening eliminates the 15-20 minute phone calls that support agents typically spend determining basic eligibility, and it operates around the clock for patients who discover cost barriers at the pharmacy counter outside of business hours.
Many patients are unaware that assistance programs exist, or they confuse copay cards with free drug programs with foundation grants. The agent serves as a knowledgeable guide, explaining the differences between program types, what each one covers, and which one applies to the patient's specific situation. According to IQVIA, patient assistance programs provided over $18 billion in free medications in 2023, yet utilization rates remain low because patients struggle to navigate the application process. A conversational AI agent that explains options in plain language and answers follow-up questions in real time closes this awareness gap at scale.
Most patient assistance applications require supporting documentation: proof of income, insurance denial letters, prescriber information, and signed consent forms. The agent collects the details needed to pre-populate application forms and tells patients exactly which documents they need to gather, reducing the back-and-forth that typically delays enrollment by weeks. Case data is assembled and pushed to your patient services platform so that when a human agent picks up the case, they have a complete file rather than starting from scratch. For pharmaceutical manufacturers processing hundreds of thousands of applications annually, this preparation step dramatically improves case throughput.
Patient assistance programs disproportionately serve populations with limited English proficiency and lower health literacy. The AI agent can be configured to support multiple languages and uses conversational prompts rather than complex forms, making the process accessible to patients who would otherwise need interpreter services or in-person help to navigate a written application. With the Census Bureau reporting that 67 million U.S. residents speak a language other than English at home, multilingual patient assistance is not a feature but a necessity for equitable program access.
Patient Assistance Agent
Get your patient assistance agent live and handling inquiries in three steps with no development resources required.
Patient Assistance Agent
FAQs
The agent asks patients a structured series of questions about their insurance status, household income range, prescribed medication, and diagnosis. These responses are compared against the eligibility criteria configured for each assistance program. Patients who meet the criteria are guided directly to enrollment steps and told what documentation they need. Those who do not qualify are redirected to alternative resources such as state pharmaceutical assistance programs, nonprofit foundations, or manufacturer copay cards that may apply to their situation. The entire screening typically takes 3-5 minutes compared to the 15-20 minute phone calls required for manual triage.
Yes. Tars is HIPAA compliant, SOC 2 Type 2 certified, GDPR compliant, and ISO 27001 certified. All patient data collected during the assistance conversation, including personal health information, insurance details, income information, and contact data, is encrypted in transit and at rest. Tars supports Business Associate Agreements for pharmaceutical companies and health systems that require them as part of their compliance framework. This is critical for patient assistance workflows where sensitive financial and medical information is exchanged.
Yes. The agent can be configured to support multiple programs with different eligibility criteria, application requirements, and enrollment workflows. This is particularly valuable for specialty pharmacies, health system foundations, and hub services providers that manage assistance programs across multiple manufacturers. Each program's rules are configured independently, and the agent routes patients to the correct program based on their medication, insurance status, and qualifying information.
Tars offers 600+ integrations, including direct connections to CRMs like HubSpot and Salesforce, case management platforms, and custom webhooks that push patient data into your existing systems. Appointment details, eligibility screening results, and collected patient information flow automatically via Zapier, native API connections, or custom webhook integrations. For pharmaceutical manufacturers and hub services, this means case data from the AI agent appears directly in your patient services platform without manual data entry.
The agent is configured with fallback pathways for patients who do not meet eligibility criteria. Rather than ending the conversation with a rejection, it redirects patients to alternative resources: state pharmaceutical assistance programs, nonprofit disease-specific foundations, manufacturer copay cards for commercially insured patients, or information about generic alternatives. The goal is to ensure every patient leaves the interaction with a next step, even if the primary program does not apply. This approach reduces frustration and maintains trust in the organization's commitment to patient access.
Yes, and this is one of the most significant advantages. The agent operates 24/7, handling eligibility questions and enrollment intake evenings, weekends, and holidays. Many patients discover medication cost barriers at the pharmacy counter, often outside of typical call center hours. A patient who learns their copay is $400 at 7 PM on a Friday needs immediate guidance, not a voicemail box. The always-available agent captures these high-intent interactions when patients are most motivated to act, preventing the abandonment that occurs when support is unavailable.
Most organizations go live within a few days. You configure your assistance programs, eligibility criteria, required documentation, and routing rules using the Tars visual editor. No coding or IT resources are required for basic deployment. The agent can be embedded as a website widget on your patient assistance portal, deployed on WhatsApp, or shared via direct link in printed materials and provider communications. More complex deployments with custom CRM integrations and multi-program configurations typically take one to two weeks.
The agent handles the high-volume, repetitive front end of the patient assistance workflow: initial eligibility screening, program explanation, FAQ responses, and document requirement communication. It does not replace your patient services team. It pre-qualifies and pre-prepares cases so that when a human agent picks up the file, they already have complete patient information and a preliminary eligibility assessment. This means your trained specialists spend their time on complex cases, appeals, and patients who need personalized guidance rather than answering the same basic eligibility questions hundreds of times per day. The result is shorter wait times, higher case throughput, and better outcomes for the patients who need the most help.
Privacy & Security
At Tars, we take privacy and security very seriously. We are compliant with GDPR, ISO, SOC 2, and HIPAA.
Email - sales@hellotars.com
.png)
%201.png)
%201.png)
